Reviewed by PillSeek Editorial Team · Last updated
About This Medication
This medication is a Brown Capsule 14 mm, Capsule with imprint "MYLAN;2100". It contains Loperamide hydrochloride 2 mg; of Loperamide hydrochloride[loperamide];. This belongs to the Opioid agonist pharmacologic class. It is manufactured by Aphena Pharma Solutions - Tennessee, LLC. For details please contact your physician.
Basic Information
- Imprint
- MYLAN;2100
- Color
- Brown
- Shape
- Capsule
- Size
- 14 mm
Drug Information
- Strength
- Loperamide hydrochloride 2 mg;
- Dosage Form
- Capsule
- RxCUI
- 978006
Pharmaceutical Classification
- Pharmacologic Class
- Opioid agonist
Related Medications
Other drugs in the same class: Opioid Agonist
- ENDOCETOXYCODONE HYDROCHLORIDE 5 mg;ACETAMINOPHEN 325 mg;WHITE • ROUND
- FENTORAFENTANYL CITRATE 100 ug;WHITE • ROUND
- FENTORAFENTANYL CITRATE 200 ug;WHITE • ROUND
- FENTORAFENTANYL CITRATE 400 ug;WHITE • ROUND
- FENTORAFENTANYL CITRATE 600 ug;WHITE • ROUND
- FENTORAFENTANYL CITRATE 800 ug;WHITE • ROUND
- Hydromorphone HydrochlorideHYDROMORPHONE HYDROCHLORIDE 2 mg;WHITE • ROUND
- Hydromorphone HydrochlorideHYDROMORPHONE HYDROCHLORIDE 4 mg;WHITE • ROUND
- Hydromorphone HydrochlorideHYDROMORPHONE HYDROCHLORIDE 8 mg;WHITE • ROUND
- HYDROmorphone HydrochlorideHYDROMORPHONE HYDROCHLORIDE 2 mg;WHITE • ROUND
Ingredients
- Active Ingredients
- Loperamide hydrochloride[loperamide];
- Inactive Ingredients
- Silicon dioxide;gelatin;ferrosoferric oxide;lactose monohydrate;magnesium stearate;cellulose, microcrystalline;sodium starch glycolate type a potato;titanium dioxide;
Additional Information
- Manufacturer
- Aphena Pharma Solutions - Tennessee, LLC
- Status (Rx/OTC)
- Rx
- Brand Names
- Diamode, Imodium, Imodium Advanced, Imodium Multi-Symptom Relief
Browse Related Pills
⚠️ Important: This information is for educational purposes only. Do not use this tool for medical diagnosis or treatment decisions. Always consult your pharmacist or healthcare provider for questions about your medications. Read full medical disclaimer.